SLC39A13

solute carrier family 39 member 13, the group of Solute carrier family 39

Basic information

Region (hg38): 11:47407132-47416496

Links

ENSG00000165915NCBI:91252OMIM:608735HGNC:20859Uniprot:Q96H72AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spondyloepimetaphyseal dysplasia-abnormal dentition syndrome (Definitive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Definitive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Supportive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ehlers-Danlos syndrome, spondylodysplastic type, 3ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Dermatologic; Musculoskeletal18985159; 18513683

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC39A13 gene.

  • Ehlers-Danlos_syndrome,_spondylocheirodysplastic_type (279 variants)
  • not_provided (94 variants)
  • Inborn_genetic_diseases (48 variants)
  • not_specified (36 variants)
  • SLC39A13-related_disorder (14 variants)
  • Ehlers-Danlos_syndrome (14 variants)
  • Connective_tissue_disorder (8 variants)
  • Mitral_valve_prolapse (1 variants)
  • Myopia (1 variants)
  • Fine-Lubinsky_syndrome (1 variants)
  • Abnormality_of_connective_tissue (1 variants)
  • Cutis_laxa (1 variants)
  • Scleroderma (1 variants)
  • Abnormality_of_the_skeletal_system (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC39A13 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001128225.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
110
clinvar
113
missense
1
clinvar
109
clinvar
12
clinvar
2
clinvar
124
nonsense
1
clinvar
2
clinvar
3
start loss
0
frameshift
3
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 0 2 118 122 2

Highest pathogenic variant AF is 0.00000247825

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC39A13protein_codingprotein_codingENST00000362021 99365
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002510.9841257070291257360.000115
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.261702230.7630.00001462347
Missense in Polyphen4874.6570.64294851
Synonymous-0.2751081041.030.00000768819
Loss of Function2.16716.40.4268.04e-7181

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002490.000246
Ashkenazi Jewish0.000.00
East Asian0.0002240.000217
Finnish0.000.00
European (Non-Finnish)0.0001430.000141
Middle Eastern0.0002240.000217
South Asian0.0001310.000131
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a zinc-influx transporter. {ECO:0000269|PubMed:21917916}.;
Disease
DISEASE: Ehlers-Danlos syndrome, spondylodysplastic type, 3 (EDSSPD3) [MIM:612350]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD3 is an autosomal recessive form characterized by a generalized skeletal dysplasia involving mainly the spine and striking clinical abnormalities of the hands, in addition to classic features of Ehlers-Danlos syndrome. Clinical features include postnatal growth retardation, moderate short stature, protuberant eyes with bluish sclerae, hands with finely wrinkled palms, atrophy of the thenar muscles, and tapering fingers. Radiologic features include mild to moderate platyspondyly, mild to moderate osteopenia of the spine, small ileum, flat proximal femoral epiphyses, short, wide femoral necks, and broad metaphyses (elbows, knees, wrists, and interphalangeal joints). {ECO:0000269|PubMed:18513683}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Nuclear Receptors Meta-Pathway;NRF2 pathway;Zinc homeostasis (Consensus)

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
0.656
rvis_EVS
0.98
rvis_percentile_EVS
90.38

Haploinsufficiency Scores

pHI
0.308
hipred
N
hipred_score
0.242
ghis
0.419

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.485

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc39a13
Phenotype
cellular phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; vision/eye phenotype;

Gene ontology

Biological process
cellular zinc ion homeostasis;response to zinc ion;connective tissue development;zinc ion transmembrane transport
Cellular component
endoplasmic reticulum;Golgi apparatus;integral component of membrane;integral component of Golgi membrane;perinuclear region of cytoplasm
Molecular function
zinc ion transmembrane transporter activity;protein binding;protein homodimerization activity